Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 264 participants.
Also called NCT01349010
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 264 participants
- Registry
-
NCT01349010
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01349010. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Probucol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Otsuka Beijing Research Institute
Record details
- Record id
cardio:ct-nct01349010- Content hash
8198f1b9fdb3483801255f3f245cd601e2fbc647cc9f11307f030f1c7ed860ab